Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 365

Results For "RI"

11066 News Found

CARE Hospitals strengthens advanced cardiac care
Hospitals | June 03, 2026

CARE Hospitals strengthens advanced cardiac care

The hospital successfully treats two complex high-risk cardiac patients using advanced minimally invasive heart surgeries


Akums secures European CEP approval for Cefpodoxime Proxetil
Drug Approval | June 03, 2026

Akums secures European CEP approval for Cefpodoxime Proxetil

The approval is expected to support the company’s presence in regulated international markets and further strengthen its position as a reliable pharma manufacturing partner


FICCI and Lilly launch Bharat Life Sciences Awards to recognise India’s scientific excellence
R&D | June 03, 2026

FICCI and Lilly launch Bharat Life Sciences Awards to recognise India’s scientific excellence

A first-of-its-kind national platform honouring the people and institutions shaping the next chapter of life sciences in India


Cancer drug “iza-bren” posts strong Phase 3 wins across multiple tumor types
Clinical Trials | June 03, 2026

Cancer drug “iza-bren” posts strong Phase 3 wins across multiple tumor types

The companies say the drug has now demonstrated clinical benefit in three separate Phase 3 trials


Granules Pharmaceuticals receives USFDA EIR for Chantilly facility
News | June 03, 2026

Granules Pharmaceuticals receives USFDA EIR for Chantilly facility

This facility plays an important role in Granules’ global manufacturing and supply network


Cipla appoints Taher Karampurwala as Senior Director and Head of Middle East Business
People | June 03, 2026

Cipla appoints Taher Karampurwala as Senior Director and Head of Middle East Business

Veteran pharmaceutical executive to relocate to Saudi Arabia and spearhead Cipla’s growth strategy across the Middle East region


Eurofragance and MartiDerm launch free skincare line to tackle 'fish odor syndrome'
News | June 03, 2026

Eurofragance and MartiDerm launch free skincare line to tackle 'fish odor syndrome'

At the center of the project is a new cosmetics line developed through collaboration between industry and medicine


FDA fast-tracks Roche’s giredestrant review as data signal potential shift in early breast cancer care
Drug Approval | June 03, 2026

FDA fast-tracks Roche’s giredestrant review as data signal potential shift in early breast cancer care

The filing is backed by Phase III data from the lidERA Breast Cancer study


Servier to acquire Edgewise muscular dystrophy business in $2.65 billion deal
News | June 03, 2026

Servier to acquire Edgewise muscular dystrophy business in $2.65 billion deal

The transaction includes an upfront payment of $1.55 billion, along with up to $1.1 billion in regulatory and commercial milestone payments